WeWork, once a high-flying startup with a $47 billion valuation, has succumbed to the pressures of the turbulent commercial real estate market, filing for Chapter...
Sandoz’s entrance into the stock market on Wednesday faced a chillier reception than expected. The biosimilar and generic drugmaker, which recently parted ways from Swiss...
In a staggering turnaround, WeWork, once pegged at a valuation of $47 billion, saw its shares plummet to near zero. The company sounded the bankruptcy...